Biochemistry blood test

DIAGNOSTIC_TEST3 trials

Sponsors

MGC Pharmaceuticals d.o.o, Tri.O Medical LTD

Conditions

Corona Virus InfectionCovid19Diabetic Foot UlcerSARS-CoV Infection

Phase 2

Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

CompletedNCT05037162

MGC Pharmaceuticals d.o.oCorona Virus Infection, Covid19

Start: 2022-10-11End: 2023-03-01Updated: 2023-03-15

Phase 3

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

MGC Pharmaceuticals d.o.oCorona Virus Infection, Covid19, SARS-CoV Infection

Start: 2021-06-11End: 2023-04-30Target: 252Updated: 2022-08-24

Unknown Phase

Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the FITT Device in Diabetic Foot Ulcers Patients

Active, not recruitingNCT06003400

Tri.O Medical LTDDiabetic Foot Ulcer

Start: 2023-03-29End: 2026-01-31Target: 20Updated: 2025-09-11